Committee advances HB 136 requiring 340B reporting after divided testimony from hospitals, payers and patient‑advocates

The House Health and Welfare Committee voted to send House Bill 136 to the House floor with a due‑pass recommendation after a day of divided testimony from hospital leaders, insurers, pharmacy owners and policy analysts. Representative Jordan Redmond (R‑District 3) introduced the bill, which would require covered entities participating in the federal 340B drug‑pricing program to report acquisition costs, payments received and the use of 340B savings; aggregate reports would be published on the State Controller’s Transparent Idaho site.

Representative Redmond said the statute’s purpose is transparency and accountability for a federal program that originally aimed to help safety‑net providers: “Without transparency into federally created programs, we wouldn’t have these findings come to light,” he said, citing national reports…